NCT03281837 - 2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA) | Biotech Hunter

Enrollment

148

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

July 9, 2020

Study Completion Date

July 16, 2020

Conditions

Osteoarthritis, KneeKnee OsteoarthritisPatellofemoral Osteoarthritis

Interventions

DEVICE

HYMOVIS plus Physical Exercise Program (PEP)

1 injection of intra-articular (IA) hyaluronan (HA), Hymovis 24mg/3ml, injection per week for 2 weeks combined with at least 8 weeks of Physical Exercise Program (PEP)

OTHER

Physical Exercise Program (PEP) alone

Physical Exercise Program (PEP) alone for at least 8 weeks

Trial Locations (10)

10016

New York University - Center for Musculoskeletal Care, New York

10021

Hospital for Special Surgery, New York

22205

IntegraTrials LLC / OrthoVirginia, Arlington

32561

Andrews Institute Orthopaedics and Sports Medicine - Andrews Research & Education Foundation, Gulf Breeze

46143

Cartilage Research Foundation, Inc. - OrthoIndy, Greenwood

85712

Tucson Orthopaedic Institute Research Center, Tucson

90045

Kerlan-Jobe Orthopaedic Clinic, Los Angeles

90048

Cedars-Sinai Medical Center, Los Angeles

91942

Horizon Clinical Research / Grossmont Orthopaedic Medical Group, San Diego

92024

CORE Orthopaedic Medical Center, Encinitas

All Listed Sponsors

lead

Fidia Pharma USA Inc.

INDUSTRY